Effectiveness of the Digital Multimedia Health Education in Improving Cancer Pain, Analgesic Adherence, and Pain Control Satisfaction With Cancer Patient (EDICAP)

March 18, 2025 updated by: National Taiwan University Hospital

According to the International Association for the Study of Pain (IASP), pain is an unpleasant sensory and emotional experience associated with, or resembling that associated with, actual or potential tissue damage . Despite advances in precision medicine, pain remains a common complaint among cancer patients, with 44.5% reporting pain and a 30.6% prevalence of moderate to severe pain. In Taiwan, over half of cancer patients experience pain in the week leading up to their outpatient visit, with 54% of oncology outpatients reporting pain issues. Of these, only 58% receive analgesics, with more medications given to those with worsening conditions. Pain significantly affects sleep, and over 50% of patients feel pain despite analgesic control. Research indicates that Asian patients often view cancer negatively, avoiding discussions about their condition, which normalizes their pain and potentially worsens it.

Enhancing patient self-efficacy can increase satisfaction with pain management, and it is recommended that healthcare professionals develop interventions to improve pain management satisfaction. Self-management interventions have shown effectiveness in improving pain-related knowledge and quality of life. These interventions can encompass patient attitudes and knowledge, with guidance and consultation from nurses reinforcing information about pain management and medication adherence.

In clinical settings, nurses may be too busy to provide comprehensive and consistent health education, leading to insufficient patient understanding of medications. Digital multimedia health education tools, which use visual aids, can better capture patients' attention and facilitate unrestricted learning regardless of time or place, leading to improved learning outcomes.

This study aims to investigate the effectiveness of "digital multimedia" in reducing pain, enhancing medication adherence, and improving pain control satisfaction among patients. The goal is to overcome the limitations of busy healthcare providers, allowing patients to learn independently, understand pain and analgesic use, dispel myths about pain medications, and enhance pain control, ultimately improving self-care capabilities, pain control satisfaction, and quality of life.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

98

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

  • Taiwan
      • New Taipei City, Taiwan, 235
        • 13F., No. 119, Ln. 136, Sec. 3, Zhongshan Rd., Zhonghe Dist., New Taipei City 235 , Taiwan (R.O.C.)
        • Contact:
        • Contact:
          • MIN CHIA WENG

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adults aged over 18 years.
  • Diagnosed with a solid tumor and reporting a pain score of 4 or higher.
  • Patients using prescribed strong opioid medications for pain management.
  • Conscious, capable of communicating in Mandarin, understanding Mandarin, or -Able to write in text.
  • Able to operate electronic devices (e.g., smartphones, tablets, or computers) independently, or with assistance from family members or caregivers.

Exclusion Criteria:

  • Patients with visual or auditory impairments.
  • Patients with cognitive impairments.
  • Diagnosed by a physician as having substance addiction (addictive substances include central nervous system depressants: opioids, heroin, ketamine; central nervous system stimulants: amphetamines, ecstasy, cocaine; and central nervous system hallucinogens: cannabis).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
Experimental: Treatment group
Digital Multimedia Health Education
Other: Digital Multimedia Health Education
This study aims to investigate the effectiveness of "digital multimedia" in reducing pain, enhancing medication adherence, and improving pain control satisfaction among patients. The goal is to overcome the limitations of busy healthcare providers, allowing patients to learn independently, understand pain and analgesic use, dispel myths about pain medications, and enhance pain control, ultimately improving self-care capabilities, pain control satisfaction, and quality of life.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cancer pain
Time Frame: From enrollment to the end of treatment at 12 weeks
This study defines its operational terms using the Taiwanese version of the Brief Pain Inventory (BPI-T). Pain is assessed through the Numerical Rating Scale (NRS), which evaluates pain severity on a scale ranging from 0 to 10. Higher scores indic.
From enrollment to the end of treatment at 12 weeks
Analgesic Adherence
Time Frame: From enrollment to the end of treatment at 12 weeks
  1. Calculate the total amount of pain medication consumed by patients and the total amount prescribed by physicians to determine the medication adherence percentage. Additionally, convert opioid prescriptions into morphine-equivalent doses to calculate the medication adherence percentage.
  2. The 4-item Morisky Medication Adherence Scale (MMAS-4) was used for assessment. This structured measurement scale was originally developed by Morisky et al. (1986) and consists of four questions. The MMAS-4 scores indicate medication adherence, with higher scores representing greater adherence to prescribed medication.
From enrollment to the end of treatment at 12 weeks
Pain Control Satisfaction
Time Frame: From enrollment to the end of treatment at 12 weeks
The Pain Treatment Satisfaction Scale (PTSS) was adopted for psychometric assessment and validation in patients with acute and chronic pain. The scale evaluates various aspects, including pain severity, information about pain and its treatment, medication therapy, the effects of current pain medications, the route of administration, medication side effects, and satisfaction with current pain medications and overall care.
From enrollment to the end of treatment at 12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2025

Primary Completion (Estimated)

October 1, 2025

Study Completion (Estimated)

November 1, 2025

Study Registration Dates

First Submitted

January 13, 2025

First Submitted That Met QC Criteria

January 19, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 18, 2025

Last Verified

October 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 202407158RINE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cancer Pain

Clinical Trials on Digital Multimedia Health Education

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe